BridgeMD
New treatment option for Parkinson Disease
Official title Accelerated Temporal Interference Stimulation on Bilateral Subthalamic Nucleus for Parkinson's Disease and Secondary Parkinson's Syndrome
ClinicalTrials.gov ID: NCT07568067
What this study is testing
- What it's testing
- This clinical trial will evaluate the efficacy of accelerated Temporal Interference Stimulation (TIS) as a therapeutic intervention for individuals diagnosed with Parkinson's disease or secondary Parkinson's syndrome. Accelerated TIS will be delivered targeting the bilateral subthalamic nuclei of the brain.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages up to 85
You may be able to join if
- Confirmed diagnosis of idiopathic Parkinson's disease or secondary parkinson's syndrome ; Hoehn-Yahr stage 1.5-3.
- Ability to walk independently.
- Ability to follow instructions, with no cognitive impairment.
- Patient and their family agree to cooperate with treatment and provide written informed consent.
You likely can't join if
- Claustrophobia or presence of metallic implants precluding MRI examination and evaluation.
- Severe dysfunction of vital organs including heart, lung, liver, kidney, etc.
- Complicated with other neurological diseases such as cerebral infarction.
- Presence of mental illness, severe depression, anxiety, etc., which may affect the accuracy of study results.
- History of deep brain stimulation (DBS) surgery.
- Patients unable or unwilling to cooperate with scale assessments.
See the full eligibility criteria
- Confirmed diagnosis of idiopathic Parkinson's disease or secondary parkinson's syndrome ; Hoehn-Yahr stage 1.5-3.
- Ability to walk independently.
- Ability to follow instructions, with no cognitive impairment.
- Patient and their family agree to cooperate with treatment and provide written informed consent.
- Claustrophobia or presence of metallic implants precluding MRI examination and evaluation.
- Severe dysfunction of vital organs including heart, lung, liver, kidney, etc.
- Complicated with other neurological diseases such as cerebral infarction.
- Presence of mental illness, severe depression, anxiety, etc., which may affect the accuracy of study results.
- History of deep brain stimulation (DBS) surgery.
- Patients unable or unwilling to cooperate with scale assessments.
- Aged over 80 years old.
The study team makes the final eligibility decision.
Where it's taking place
- Guangzhou, Guangdong, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, up to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Guangzhou, Guangdong, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.